GDRX Jan 2026 5.000 call
| Previous Close | 3.4500 |
| Open | 3.4500 |
| Bid | 3.3000 |
| Ask | 5.6000 |
| Strike | 5.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 3.4500 - 3.4500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 314 |
Business WireSimon Patterson Joins GoodRx Board of Directors
SANTA MONICA, Calif., May 30, 2024--GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced the election of Simon Patterson to its Board of Directors. Currently leading EMEA operations for the technology investment firm Silver Lake, Mr. Patterson brings to GoodRx decades of technology, strategy and management experience. Mr. Patterson also serves on the boards of IVC Evidensia, New Zealand Rugby Commercial, RAC, and ZPG, and previously served on the b
Business WireGoodRx Named One of the 2024 TIME100 Most Influential Companies
SANTA MONICA, Calif., May 30, 2024--Today, GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. This is the second time GoodRx has received this honor for helping Americans get the medications they need at a price they can afford.
- Investing.com
Street calls of the week: Upgrades for Micron, Magnite and GoodRx Holdings
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Micron, Magnite and GoodRx Holdings; downgrade for Him Hers Health.
